Literature DB >> 30697128

An Introduction to Pharmacotherapy for Inborn Errors of Metabolism.

Aaron A Harthan.   

Abstract

Inborn errors of metabolism comprise a wide array of diseases and complications in the pediatric patient. The rarity of these disorders limits the ability to conduct and review robust literature regarding the disease states, mechanisms of dysfunction, treatments, and outcomes. Often, treatment plans will be based on the pathophysiology associated with the disorder and theoretical agents that may be involved in the metabolic process. Medication therapies usually consist of natural or herbal products. Established efficacious pediatric doses for these products are difficult to find in tertiary resources, and adverse effects are routinely limited to single case reports. This review article attempts to summarize some of the more common inborn errors of metabolism in a manner that is applicable to pharmacists who will provide care for these patients.

Entities:  

Keywords:  dietary supplements; drug therapy; inborn errors; metabolism; review

Year:  2018        PMID: 30697128      PMCID: PMC6336179          DOI: 10.5863/1551-6776-23.6.432

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  93 in total

1.  Pyruvate carboxylase deficiency. Report of a case and additional evidence for the "mild" phenotype.

Authors:  G L Arnold; M L Griebel; M Porterfield; M Brewster
Journal:  Clin Pediatr (Phila)       Date:  2001-09       Impact factor: 1.168

2.  Pediatric congenital errors of metabolism: the pharmacist's extended role.

Authors:  Christopher Cutts
Journal:  Am J Health Syst Pharm       Date:  2003-01-15       Impact factor: 2.637

3.  Successful pregnancy in a treated patient with biotinidase deficiency.

Authors:  C J Hendriksz; M A Preece; A Chakrapani
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Vitamin C for prophylaxis of tyrosinemia in the newborn. Statement by the Nutrition Committee of the Canadian Paediatric Society.

Authors: 
Journal:  Can Med Assoc J       Date:  1976-03-06       Impact factor: 8.262

5.  Anaphylaxis to riboflavin (vitamin B2).

Authors:  L S Ou; M L Kuo; J L Huang
Journal:  Ann Allergy Asthma Immunol       Date:  2001-11       Impact factor: 6.347

Review 6.  Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference.

Authors:  Garabed Eknoyan; Derrick L Latos; Jill Lindberg
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

7.  A model of human phenylalanine metabolism in normal subjects and in phenylketonuric patients.

Authors:  S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency.

Authors:  Mette C ØRngreen; Mette G Nørgaard; Massimo Sacchetti; Baziel G M van Engelen; John Vissing
Journal:  Ann Neurol       Date:  2004-08       Impact factor: 10.422

9.  Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy.

Authors:  Johan L K Van Hove; Rita Van Damme-Lombaerts; Stephanie Grünewald; Heidi Peters; Boudewijn Van Damme; Jean-Pierre Fryns; Jozef Arnout; Ron Wevers; E Regula Baumgartner; Brian Fowler
Journal:  Am J Med Genet       Date:  2002-08-01

Review 10.  Management and emergency treatments of neonates with a suspicion of inborn errors of metabolism.

Authors:  Hélène Ogier de Baulny
Journal:  Semin Neonatol       Date:  2002-02
View more
  2 in total

1.  Knowledge and perception of inborn errors of metabolism (IEMs) among healthcare students at a selected public university in Klang Valley, Malaysia.

Authors:  Shi Hui Liew; Jing Ying Lim; Hanis Mastura Yahya; Roslee Rajikan
Journal:  Intractable Rare Dis Res       Date:  2022-08

2.  Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism.

Authors:  Ning Liu; Jing Xiao; Charul Gijavanekar; Kirk L Pappan; Kevin E Glinton; Brian J Shayota; Adam D Kennedy; Qin Sun; V Reid Sutton; Sarah H Elsea
Journal:  JAMA Netw Open       Date:  2021-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.